Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker NMRK
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | SCHEDULE 13G/A (amended) | NMRK Newmark Group, Inc. | Vanguard Portfolio Management | 16.09M | 10.1% | SCHEDULE 13G/A ↗ |
| Oct 30, 2026 | SCHEDULE 13G/A (amended) | NMRK Newmark Group, Inc. | Vanguard Portfolio Management | 15.71M | 9.8% | SCHEDULE 13G/A ↗ |
| Oct 30, 2026 | SCHEDULE 13G | NMRK Newmark Group, Inc. | Vanguard Capital Management | 8.51M | 5.3% | SCHEDULE 13G ↗ |
| Apr 29, 2026 | SCHEDULE 13G | NMRK Newmark Group, Inc. | Vanguard Portfolio Management | 13.90M | 8.5% | SCHEDULE 13G ↗ |
| Mar 27, 2026 | SCHEDULE 13G/A (amended) | NMRK Newmark Group, Inc. | The Vanguard Group | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Oct 31, 2025 | SCHEDULE 13G/A (amended) | NMRK Newmark Group, Inc. | The Vanguard Group | 21.13M | 13.6% | SCHEDULE 13G/A ↗ |
| Oct 6, 2025 | SCHEDULE 13D/A (amended) | NMRK Newmark Group, Inc. | Howard W. Lutnick | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Oct 6, 2025 | SCHEDULE 13D/A (amended) | NMRK Newmark Group, Inc. | Brandon G. Lutnick | 44.03M | 22.3% | SCHEDULE 13D/A ↗ |
| Oct 6, 2025 | SCHEDULE 13D/A (amended) | NMRK Newmark Group, Inc. | CF Group Management, Inc. | 40.66M | 20.5% | SCHEDULE 13D/A ↗ |
| Oct 6, 2025 | SCHEDULE 13D/A (amended) | NMRK Newmark Group, Inc. | Cantor Fitzgerald, L.P. | 39.28M | 19.9% | SCHEDULE 13D/A ↗ |
| May 19, 2025 | SCHEDULE 13D/A (amended) | NMRK Newmark Group, Inc. | Howard W. Lutnick | 43.14M | 22.4% | SCHEDULE 13D/A ↗ |
| May 19, 2025 | SCHEDULE 13D/A (amended) | NMRK Newmark Group, Inc. | CF Group Management, Inc. | 40.66M | 21.0% | SCHEDULE 13D/A ↗ |
| May 19, 2025 | SCHEDULE 13D/A (amended) | NMRK Newmark Group, Inc. | Cantor Fitzgerald, L.P. | 39.28M | 20.5% | SCHEDULE 13D/A ↗ |
| Apr 30, 2025 | SCHEDULE 13G/A (amended) | NMRK Newmark Group, Inc. | The Vanguard Group | 20.05M | 12.6% | SCHEDULE 13G/A ↗ |
| Feb 19, 2025 | SCHEDULE 13D/A (amended) | NMRK Newmark Group, Inc. | Howard W. Lutnick | 53.99M | 27.1% | SCHEDULE 13D/A ↗ |
| Feb 19, 2025 | SCHEDULE 13D/A (amended) | NMRK Newmark Group, Inc. | CF Group Management, Inc. | 40.67M | 20.3% | SCHEDULE 13D/A ↗ |
| Feb 19, 2025 | SCHEDULE 13D/A (amended) | NMRK Newmark Group, Inc. | Cantor Fitzgerald, L.P. | 39.29M | 19.8% | SCHEDULE 13D/A ↗ |
17 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 11:04 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances